The article below may contain offensive and/or incorrect content.
c9ASO, an investigational ASO drug, targets the TDP-43 protein, reducing its buildup and decreasing neurological decline associated with ALS and FTD.Article Correctness Is Author's Responsibility: Investigational Drug Stops Toxic Proteins Tied To ALS
c9ASO, an investigational ASO drug, targets the TDP-43 protein, reducing its buildup and decreasing neurological decline associated with ALS and FTD.
